Crenigacestat

N/A

Report date: 2025/09/12 20:01:19
NME

Base Information

Drug NameCrenigacestat
Drug Alias NameCrenigacestat - Eli Lilly and CompanyJSMD-194LY-3039478BMS-986405
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurogenic locus notch homolog protein 1 inhibitors
TargetsNeurogenic locus notch homolog protein 1
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisColonic Neoplasms +[18
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesItaly +[10
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Active IndicationsSolid tumours
Inactive IndicationsNeoplasm MetastasisColonic NeoplasmsTriple Negative Breast Neoplasms +[17

Other Information

ATC CodeN/A
Related LinksN/A